These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2259755)

  • 1. Interspecies comparisons in toxicology: the utility and futility of plasma concentrations of the test substance.
    Monro AM
    Regul Toxicol Pharmacol; 1990 Oct; 12(2):137-60. PubMed ID: 2259755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug toxicokinetics: scope and limitations that arise from species differences in pharmacodynamic and carcinogenic responses.
    Monro A
    J Pharmacokinet Biopharm; 1994 Feb; 22(1):41-57. PubMed ID: 8027948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is an appropriate measure of exposure when testing drugs for carcinogenicity in rodents?
    Monro A
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):171-81. PubMed ID: 1539156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of animal pharmacokinetic and pharmacodynamic data in drug safety assessment.
    Smith DA
    Eur J Drug Metab Pharmacokinet; 1993; 18(1):31-9. PubMed ID: 8335037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, metabolism, and other factors that influence drug exposure in toxicology studies.
    Mayer PR
    Toxicol Pathol; 1995; 23(2):165-9. PubMed ID: 7569671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I).
    Chiou WL
    Clin Pharmacokinet; 1989 Sep; 17(3):175-99. PubMed ID: 2680213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics in toxicology.
    Smith DA
    Xenobiotica; 1997 May; 27(5):513-25. PubMed ID: 9179991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicokinetics in the National Toxicology Program.
    Goehl TJ
    NIDA Res Monogr; 1997; 173():273-304. PubMed ID: 9260193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapolation of animal toxicity to humans: interspecies comparisons in drug development.
    Voisin EM; Ruthsatz M; Collins JM; Hoyle PC
    Regul Toxicol Pharmacol; 1990 Oct; 12(2):107-16. PubMed ID: 2259752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saturable metabolism and its relationship to toxicity.
    Andersen ME
    Crit Rev Toxicol; 1981 May; 9(2):105-50. PubMed ID: 7026174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats.
    Stecklair KP; Hamburger DR; Egorin MJ; Parise RA; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):375-82. PubMed ID: 11761455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Toxicity Prediction in Multiple Species by Leveraging Mechanistic ToxCast Mitochondrial Inhibition Data and Simulation of Oral Bioavailability.
    Bhhatarai B; Wilson DM; Bartels MJ; Chaudhuri S; Price PS; Carney EW
    Toxicol Sci; 2015 Oct; 147(2):386-96. PubMed ID: 26139166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models for assessing the relationship between drug concentration and drug effect in performance horses.
    Kamerling SG; Owens JG
    Br Vet J; 1994; 150(6):507-25. PubMed ID: 7850442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of pharmacokinetics in designing toxicological protocols and improving interspecies extrapolation.
    Young JF; Holson JF
    J Environ Pathol Toxicol; 1978; 2(1):169-86. PubMed ID: 722219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
    Willhite CC; Ball GL; McLellan CJ
    Crit Rev Toxicol; 2012 May; 42(5):358-442. PubMed ID: 22512666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
    Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and Pharmacodynamic Principles for Toxicology.
    Lista AD; Sirimaturos M
    Crit Care Clin; 2021 Jul; 37(3):475-486. PubMed ID: 34053701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.